| MET |
MET: Hepatocyte growth factor receptor precursor |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
0.848 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
0.848 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
0.848 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
TMPRSS9 |
IPI00337305 |
0.848 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
LOC643930 |
CCL3L1, D17S1718, G0S19-2, SCYA3L1: Small-inducible cytokine A3-like 1 precursor |
0.848 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
0.848 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
0.848 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
0.848 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
LOC643930 |
CCL3L1, D17S1718, G0S19-2, SCYA3L1: Small-inducible cytokine A3-like 1 precursor |
0.848 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.848 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
0.848 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
0.848 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
0.848 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
STAT3 |
|
0.848 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.848 |
Evidence |
|